相似文献
1
Rash and edema shortly after initial exposure to low dose cenobamate.
Epilepsy Behav Rep. 2025 Jun 27;31:100800. doi: 10.1016/j.ebr.2025.100800. eCollection 2025 Sep.
2
Cenobamate add-on therapy for drug-resistant focal epilepsy.
Cochrane Database Syst Rev. 2024 Aug 1;8(8):CD014941. doi: 10.1002/14651858.CD014941.pub2.
3
Real-world utilization of Cenobamate as adjunct therapy in office-based neurology: practical tips and insights for titration.
Front Neurol. 2025 Jun 13;16:1558614. doi: 10.3389/fneur.2025.1558614. eCollection 2025.
4
Cenobamate Monotherapy for Focal Epilepsy: A Single-Center Retrospective Study.
Neurol Clin Pract. 2025 Jun;15(3):e200460. doi: 10.1212/CPJ.0000000000200460. Epub 2025 Apr 1.
5
Cenobamate as add-on treatment in ultra-refractory focal epilepsy: Real-world results from The Danish Epilepsy Centre, Dianalund, Denmark.
Neurol Sci. 2025 Apr 15. doi: 10.1007/s10072-025-08174-y.
6
A french real-world experience with cenobamate in patients with drug-resistant focal epilepsy: A retrospective observational study.
Epilepsy Behav Rep. 2025 Jun 2;31:100782. doi: 10.1016/j.ebr.2025.100782. eCollection 2025 Sep.
7
The Effectiveness of Cenobamate in Patients Treated With Vagus Nerve Stimulation for Drug Resistant Epilepsy.
Eur J Neurol. 2025 Jun;32(6):e70229. doi: 10.1111/ene.70229.
8
Real-world effectiveness and tolerability of cenobamate in drug-resistant epilepsy: A retrospective analysis of the patients included into the Early Access Programs (EAP) in Germany, France, and United Kingdom.
Epilepsia Open. 2025 Mar 22. doi: 10.1002/epi4.70021.
9
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
10
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD001901. doi: 10.1002/14651858.CD001901.pub2.
引用本文的文献
1
Cutaneous adverse reactions to low doses of cenobamate: don't DRESS it up…tell the truth!
Neurol Sci. 2025 Aug 19. doi: 10.1007/s10072-025-08429-8.
本文引用的文献
1
Drug-induced subacute cutaneous lupus erythematous from cenobamate: case presentation and review of the literature.
Dermatol Online J. 2024 Dec 15;30(6). doi: 10.5070/D330664689.
2
Real-world use of cenobamate in adults: Efficacy and predictors of treatment response.
Epilepsia. 2025 May;66(5):1492-1504. doi: 10.1111/epi.18297. Epub 2025 Feb 11.
3
Effectiveness and tolerability of cenobamate: A single center experience.
Epilepsy Res. 2025 Jan;209:107498. doi: 10.1016/j.eplepsyres.2024.107498. Epub 2024 Dec 19.
4
Distinguishing DRESS syndrome from drug rash and eosinophilia: Beyond RegiSCAR criteria.
J Allergy Clin Immunol Glob. 2024 Sep 19;3(4):100346. doi: 10.1016/j.jacig.2024.100346. eCollection 2024 Nov.
5
A global update on cenobamate based on real-world experience in over 100 000 patients.
Epilepsia. 2024 Apr;65(4):1149-1150. doi: 10.1111/epi.17935. Epub 2024 Mar 6.
6
Adjunctive cenobamate in highly active and ultra-refractory focal epilepsy: A "real-world" retrospective study.
Epilepsia. 2023 May;64(5):1225-1235. doi: 10.1111/epi.17549. Epub 2023 Feb 27.
7
Initial Real-World Experience With Cenobamate in Adolescents and Adults: A Single Center Experience.
Pediatr Neurol. 2022 Apr;129:19-23. doi: 10.1016/j.pediatrneurol.2022.01.001. Epub 2022 Jan 21.
8
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
CNS Drugs. 2021 Sep;35(9):935-963. doi: 10.1007/s40263-021-00827-8. Epub 2021 Jun 18.
9
The ups and downs of alkyl-carbamates in epilepsy therapy: How does cenobamate differ?
Epilepsia. 2021 Mar;62(3):596-614. doi: 10.1111/epi.16832. Epub 2021 Feb 13.
10
Cenobamate tablets as a treatment for focal-onset seizures in adults.
Expert Rev Clin Pharmacol. 2021 Feb;14(2):161-172. doi: 10.1080/17512433.2021.1879637. Epub 2021 Jan 26.
Zotero 插件